InvestorsHub Logo
Followers 48
Posts 4547
Boards Moderated 0
Alias Born 10/26/2016

Re: None

Wednesday, 01/09/2019 10:45:49 PM

Wednesday, January 09, 2019 10:45:49 PM

Post# of 3854

https://www.forbes.com/sites/julieweed/2018/12/15/predictions-for-cannabis-2019-from-entrepreneurs-on-the-front-lines/


Alex Wasyl, chief executive, Nexien BioPharma hopes cannabis will come off the list of Schedule 1 substances on 2019 so it can be “developed, studied, approved, regulated, and prescribed like any other true medicine.” His company which was founded in 2017 in Colorado is a pharmaceutical firm engaged in the formulation, development, and commercialization of cannabinoid-based medications.

In the meantime, businesses will wait to see what the latest Farm Bill and Jeff Sessions’ replacement as Attorney General will bring.

In the US, states will continue to debate where taxes go. A Colorado state report showed that marijuana sales generated $247 million in tax revenue.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NXEN News